| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/07/2023 | IDEAYA Biosciences, Inc. | IDYA | Grant | Stock Option (right to buy) | 16.2k | $25.40 | $411.5k | | 06/07/2023 |
| 01/17/2023 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 3.3k | $21.27 | $69.5k | | 01/17/2023 |
| 06/23/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 18.5k | $13.98 | $258.6k | | 06/23/2022 |
| 06/23/2022 | Dare Bioscience, Inc. | DARE | Grant | Stock Option (right to buy) | 38k | $1.31 | $49.8k | | 06/23/2022 |
| 06/09/2022 | IDEAYA Biosciences, Inc. | IDYA | Grant | Stock Option (right to buy) | 11k | $12.29 | $135.2k | | 06/09/2022 |
| 06/09/2022 | IDEAYA Biosciences, Inc. | IDYA | Grant | Stock Option (right to buy) | 11k | $12.29 | $135.2k | | 06/09/2022 |
| 01/18/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 9.6k | $8.27 | $79.1k | | 01/18/2022 |
| 06/24/2021 | Dare Bioscience, Inc. | DARE | Grant | Stock Option (right to buy) | 30k | $1.46 | $43.8k | | 06/24/2021 |
| 06/23/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $35.86 | $430.3k | | 06/23/2021 |
| 02/12/2021 | IDEAYA Biosciences, Inc. | IDYA | Grant | Stock Option (right to buy) | 22k | $18.91 | $416k | | 02/12/2021 |
| 02/12/2021 | IDEAYA Biosciences, Inc. | IDYA | Grant | Stock Option (right to buy) | 22k | $18.91 | $416k | | 02/12/2021 |
| 07/15/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 723 | $53.41 | $38.6k | | 07/15/2020 |
| 06/25/2020 | Dare Bioscience, Inc. | DARE | Grant | Stock Option (right to buy) | 22.5k | $1.03 | $23.2k | | 06/25/2020 |
| 06/10/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 12k | $56.46 | $677.5k | | 06/10/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 20k | $2.48 | $49.6k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Other | Common Stock | 50k | $20.00 | $1000k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 30k | $6.96 | $208.8k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 15k | $6.71 | $100.6k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 15k | $5.82 | $87.3k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 15k | $2.78 | $41.7k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 15k | $1.42 | $21.3k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 15k | $1.80 | $27k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 20k | $1.68 | $33.6k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 20k | $1.23 | $24.6k | | 01/16/2020 |
| 01/16/2020 | ARQULE INC | ARQL | Disposition | Stock Option (Right to Buy) | 40k | $6.21 | $248.4k | | 01/16/2020 |
| 07/08/2019 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 24k | $22.49 | $539.8k | | 07/08/2019 |
| 06/13/2019 | Dare Bioscience, Inc. | DARE | Grant | Stock Option (right to buy) | 22.5k | $0.90 | $20.2k | | 06/13/2019 |
| 05/14/2019 | ARQULE INC | ARQL | Grant | Director Stock Options | 40k | $6.21 | $248.4k | | 05/14/2019 |
| 04/02/2019 | Immune Design Corp. | IMDZ | Disposition | Stock Option (Rt to Buy) | 10k | $5.60 | $56k | | 04/02/2019 |
| 04/02/2019 | Immune Design Corp. | IMDZ | Disposition | Stock Option (Rt to Buy) | 12.5k | $4.05 | $50.6k | | 04/02/2019 |
| 04/02/2019 | Immune Design Corp. | IMDZ | Disposition | Stock Option (Rt to Buy) | 12.5k | $1.31 | $16.4k | | 04/02/2019 |
| 01/03/2019 | Immune Design Corp. | IMDZ | Grant | Stock Option (right to buy) | 12.5k | $1.31 | $16.4k | | 01/03/2019 |
| 07/10/2018 | Dare Bioscience, Inc. | DARE | Grant | Stock Option (right to buy) | 45k | $1.35 | $60.8k | | 07/10/2018 |
| 05/08/2018 | ARQULE INC | ARQL | Grant | Director Stock Options | 20k | $2.48 | $49.6k | | 05/08/2018 |
| 01/04/2018 | Immune Design Corp. | IMDZ | Grant | Stock Option (right to buy) | 12.5k | $4.05 | $50.6k | | 01/04/2018 |
|